TASTYLIA 5

What is TASTYLIA 5?

TASTYLIA 5 is a modern medicinal product belonging to the pharmacological group of selective phosphodiesterase type 5 (PDE-5) inhibitors. The primary purpose of the product is to restore and maintain erectile function in men who face difficulties in achieving or maintaining an erection sufficient for satisfactory sexual intercourse. The drug is available in the form of film-coated tablets, which ensures convenient oral administration and dosing accuracy. The manufacturer of TASTYLIA 5 is the Indian pharmaceutical company Healing Pharma, which specializes in producing high-quality generics in compliance with international GMP standards. Thanks to the optimal dosage of the active substance, the drug is characterized by a mild yet pronounced therapeutic effect.

The active component of TASTYLIA 5 is tadalafil at a dose of 5 milligrams, which is a recognized agent in global urological practice for the treatment of erectile dysfunction. A feature of this dose is the possibility of daily use, allowing the patient not to tie sexual activity to a tablet intake schedule. This approach provides more natural spontaneity in intimate relationships, reducing psychological pressure associated with anticipating the drug's effect. In addition, TASTYLIA 5 demonstrates high bioavailability and a long half-life, which favorably distinguishes it among other representatives of the group. This allows for maintaining a stable concentration of the active substance in blood plasma, which is especially important for patients with chronic forms of potency disorders.

The pharmacokinetic properties of tadalafil involve rapid absorption in the gastrointestinal tract, while food intake does not significantly affect the drug's efficacy. TASTYLIA 5 by Healing Pharma undergoes strict quality control at all stages of production, guaranteeing compliance with the stated composition and therapeutic action. The drug is used exclusively as prescribed by a physician following appropriate diagnostics and the exclusion of possible contraindications. Its use is aimed at improving a man's quality of life and restoring self-confidence. It is worth noting that the action of the drug is realized only in the presence of natural sexual stimulation; therefore, it does not cause a spontaneous erection without corresponding arousal.

What is TASTYLIA 5 prescribed for?

The main indication for the use of TASTYLIA 5 is erectile dysfunction of various origins, characterized by the inability to achieve or maintain an erection necessary for satisfactory sexual intercourse. This condition can be caused by psychological factors such as stress, anxiety, or depressive disorders, as well as organic causes, including vascular pathologies, diabetes mellitus, or hormonal changes. Thanks to its mechanism of action aimed at relaxing the smooth muscles of the penile vessels, the drug helps enhance blood flow to the cavernous bodies. This ensures the achievement of a stable and high-quality erection with adequate sexual stimulation. It is important to understand that TASTYLIA 5 is not an aphrodisiac and does not increase libido, but only restores the physiological response to arousal.

A separate area of application for TASTYLIA 5 is the therapy of symptoms of benign prostatic hyperplasia (BPH). In this case, the drug helps reduce the severity of such unpleasant manifestations as frequent urination, nocturia (nighttime urges to urinate), a feeling of incomplete bladder emptying, and a weak urine stream. This effect is achieved due to the relaxation of smooth muscles in the prostate area and the bladder neck, which reduces urethral obstruction. Daily intake of a low dose of tadalafil allows for effective control of BPH symptoms and improves urodynamic indicators. This makes TASTYLIA 5 the drug of choice for patients experiencing a combination of erectile dysfunction and urinary disorders.

In clinical practice, TASTYLIA 5 may also be prescribed as part of comprehensive rehabilitation after radical prostatectomy or other surgical interventions on pelvic organs. Restoration of erectile function after such surgeries is a lengthy process, and regular intake of PDE-5 inhibitors helps maintain tissue trophism and prevents the development of cavernous fibrosis. In addition, the drug can be beneficial for men with a psychogenic form of erectile dysfunction, as reducing the fear of failure due to confidence in the medication's effect often breaks the vicious cycle of anxiety. Prescribing the drug must always take place after a thorough history taking and an assessment of the patient's cardiovascular risk. The doctor determines the appropriateness of use and the optimal dosage regimen depending on the individual clinical picture.

Composition and active components of TASTYLIA 5

The main active substance of TASTYLIA 5 is tadalafil at a concentration of 5 milligrams per tablet. Tadalafil belongs to the class of highly selective inhibitors of the enzyme phosphodiesterase type 5, which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penile blood vessels. By blocking the action of this enzyme, tadalafil promotes the accumulation of cGMP, leading to prolonged relaxation of the vascular wall and an increased inflow of arterial blood to the cavernous bodies. This process is key to forming and maintaining a stable erection in response to sexual stimulation. A unique property of tadalafil is its long half-life, which is about 17.5 hours, significantly exceeding similar indicators of other drugs in the group.

Auxiliary components in TASTYLIA 5 serve as excipients, providing stability to the tablet, its proper mechanical strength, and optimal release of the active substance in the gastrointestinal tract. The coating includes hypromellose, lactose monohydrate, croscarmellose sodium, microcrystalline cellulose, magnesium stearate, and colorants that give the tablet its characteristic appearance. These substances are pharmacologically neutral; however, patients with rare hereditary lactose intolerance should take its presence in the composition into account. The manufacturer Healing Pharma uses high-quality raw materials, which minimizes the risk of allergic reactions and ensures predictable bioavailability of the drug. Quality control in production guarantees the absence of extraneous impurities and compliance of each batch with stated specifications.

The mechanism of action of tadalafil also extends to the pelvic blood vessels, which explains its effectiveness in treating symptoms of benign prostatic hyperplasia. Relaxation of the smooth musculature of the prostate gland and bladder neck reduces resistance to urine flow and facilitates urination. It is important to emphasize that TASTYLIA 5 does not directly affect the hormonal background or testosterone levels, acting exclusively on the vascular-muscular component of an erection. This makes the drug safe for long-term use in most patients without the risk of suppressing their own endocrine function. The combination of high selectivity and long duration of action provides a favorable profile of efficacy and tolerability.

TASTYLIA 5 Dosage

The standard recommended dose of TASTYLIA 5 for adult men is one tablet (5 mg) once daily. This dosage regimen involves continuous daily intake of the drug at approximately the same time, regardless of planned sexual activity. This approach allows for achieving a steady-state concentration of tadalafil in blood plasma, which ensures constant readiness for sexual intercourse at any moment. Unlike situational administration of higher doses, daily use of 5 mg minimizes fluctuations in drug concentration and reduces the likelihood of side effects. The duration of the treatment course is determined individually by a physician, depending on the severity of erectile dysfunction and the patient's response to therapy.

For elderly patients, dose adjustment of TASTYLIA 5 is usually not required, as age-related changes in the pharmacokinetics of tadalafil are not clinically significant. However, in individuals with severe renal insufficiency (creatinine clearance less than 30 mL/min), daily intake of the drug is not recommended due to the risk of active substance accumulation. In such cases, the doctor may consider alternative treatment regimens or transfer the patient to situational intake of lower doses at longer intervals. Patients with severe hepatic impairment should also use TASTYLIA 5 with caution, as drug metabolism occurs mainly in the liver with the participation of cytochrome CYP3A4. The decision on the possibility of use and dose adjustment in such cases is made exclusively by a qualified specialist.

It is important not to exceed the recommended daily dose, as this does not lead to an increased therapeutic effect but significantly increases the risk of adverse reactions. If a patient accidentally takes a double dose, immediate medical advice should be sought, especially in the presence of chest pain, dizziness, or a pronounced drop in blood pressure. TASTYLIA 5 is not intended for use in women and persons under 18 years of age, as the safety and efficacy of the drug in these groups have not been studied. Compliance with the prescribed dosage regimen is the key to achieving an optimal therapeutic result and minimizing health risks.

How to take TASTYLIA 5 correctly?

TASTYLIA 5 tablet should be taken orally, swallowed whole with a sufficient amount of water, regardless of meals. The drug can be taken either on an empty stomach or after eating, as fatty food does not significantly affect the rate and extent of tadalafil absorption. To maintain a stable concentration of the active substance in the body, it is recommended to take the tablet daily at the same time, for example, in the morning after waking up or in the evening before sleep. Such regularity helps build a habit and reduces the likelihood of a missed dose. It is important to understand that TASTYLIA 5 acts only in the presence of sexual excitement, so expecting a spontaneous erection without stimulation is incorrect.

If a patient misses a regular dose of TASTYLIA 5, he should take the tablet as soon as he remembers, provided that there is enough time before the next scheduled dose. In the event that the time for the next dose is approaching, the missed tablet should be skipped and the regular schedule continued without doubling the dose to compensate. Taking two tablets at the same time is strictly prohibited, as this can lead to an overdose and the development of serious side effects. During the course of treatment, it is recommended to avoid excessive alcohol consumption, as ethanol can enhance the hypotensive effect of the drug and increase the risk of orthostatic reactions. It is also advised to refrain from consuming large amounts of grapefruit juice, as it can affect tadalafil metabolism.

Before starting TASTYLIA 5, the patient must undergo a medical examination to exclude cardiovascular diseases in which sexual activity is dangerous. The doctor must evaluate general health, blood pressure level, and the presence of concomitant pathologies that may affect the safety of therapy. In the event of a sudden deterioration in vision or hearing while taking the drug, it is necessary to immediately stop its use and seek emergency medical assistance. It should also be remembered that TASTYLIA 5 does not protect against sexually transmitted infections, so barrier contraception methods must be used. Following these recommendations allows for the safest and most effective use of the drug to restore sexual function.

Side effects of TASTYLIA 5

The most common side effects of TASTYLIA 5 are headache, dyspeptic disorders (a feeling of heaviness in the stomach, nausea), back pain, myalgia (muscle pain), and nasal congestion. These reactions are usually mild or moderate in nature, occur primarily at the beginning of therapy, and disappear on their own within a few days without the need to discontinue the drug. Facial flushing and skin redness are also common consequences of vasodilation caused by the action of tadalafil. Back and muscle pain usually appears 12–24 hours after taking the tablet and gradually resolves within 48 hours. If these symptoms become intense or prolonged, it is recommended to consult a doctor to adjust therapy.

Less common adverse reactions include dizziness, palpitations, increased fatigue, eyelid edema, eye pain, and conjunctival hyperemia. In rare cases, the development of priapism—a prolonged and painful erection lasting more than 4 hours—is possible, which requires immediate medical attention to prevent irreversible damage to penile tissues. Isolated cases of sudden hearing or vision loss associated with taking PDE-5 inhibitors have also been described, although a causal relationship has not always been confirmed. Patients with a history of retinitis pigmentosa or non-arteritic anterior ischemic optic neuropathy should use the drug with extreme caution. The appearance of any unusual symptoms is a reason to consult a doctor.

An individual's response to TASTYLIA 5 may vary depending on age, overall health, presence of concomitant diseases, and simultaneous intake of other medications. In most patients, the drug is well tolerated, and the incidence of side effects decreases with long-term regular use. If undesirable phenomena persist or worsen, the doctor may consider reducing the dose or switching to an alternative treatment regimen. Unauthorized discontinuation of the drug without consulting a specialist is not recommended, as this may lead to the return of the underlying disease symptoms. Contacting a doctor is mandatory if chest pain, severe shortness of breath, or allergic reactions occur.

Contraindications of TASTYLIA 5

An absolute contraindication to the use of TASTYLIA 5 is hypersensitivity to tadalafil or any excipient of the drug. The drug is strictly prohibited for patients who continuously or intermittently take organic nitrates (nitroglycerin, isosorbide dinitrate, amyl nitrite) in any dosage forms, as the combination with PDE-5 inhibitors can cause a life-threatening drop in blood pressure. TASTYLIA 5 must also not be used in patients with severe cardiovascular diseases, including recent myocardial infarction (within the last 90 days), unstable angina, NYHA Class II–IV heart failure, or uncontrolled arrhythmia. Sexual activity itself is a physical strain, so in the presence of such conditions, it poses a significant health risk.

TASTYLIA 5 is not prescribed to patients who have lost vision in one eye due to non-arteritic anterior ischemic optic neuropathy, regardless of whether this was associated with taking PDE-5 inhibitors. Severe hepatic impairment (Child-Pugh Class C) and end-stage renal disease requiring hemodialysis are also contraindications for daily intake of the drug. The drug is not used in women, children, and adolescents under 18 years of age, as there are no safety and efficacy data for these groups. Patients with rare hereditary galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome should avoid taking TASTYLIA 5 due to the lactose content in the tablet.

Relative contraindications requiring special caution and a thorough risk/benefit assessment include a predisposition to priapism, anatomical deformation of the penis (Peyronie's disease, angiofibroma, cavernous fibrosis), sickle cell anemia, multiple myeloma, and leukemia. Before prescribing the drug, the physician must conduct a complete medical examination, including an evaluation of the cardiovascular system, to rule out occult pathologies. Patients with arterial hypotension (blood pressure below 90/50 mmHg) or uncontrolled hypertension require stabilization of their condition before starting therapy. Consultation with a doctor is mandatory before taking TASTYLIA 5, as only a specialist can determine the presence of individual limitations and the safety of drug administration.

Interaction of TASTYLIA 5 with other drugs and alcohol

The most dangerous drug interaction of TASTYLIA 5 is its combination with organic nitrates and nitric oxide donors used to treat angina and ischemic heart disease. Simultaneous administration of these agents leads to a synergistic vasodilation and a critical drop in blood pressure, which can provoke collapse, loss of consciousness, or even a fatal outcome. The patient must inform the doctor about all medications being taken, especially if these are nitrates in the form of tablets, sprays, patches, or injections. Simultaneous use of TASTYLIA 5 with alpha-blockers (doxazosin, tamsulosin) should also be avoided, as this can enhance the hypotensive effect and cause dizziness. If the combination is necessary, it is prescribed with an interval of at least 4 hours between drug intakes.

CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, erythromycin, and clarithromycin can increase tadalafil concentration in the blood, which requires a reduction in TASTYLIA 5 dose. Conversely, CYP3A4 inducers (rifampicin, carbamazepine, phenytoin, St. John's wort) accelerate the metabolism of the drug and reduce its efficacy. Moderate alcohol consumption usually does not significantly affect the action of tadalafil; however, excessive alcohol consumption can enhance vasodilation and lead to pronounced dizziness or orthostatic hypotension. Patients are advised to limit alcohol consumption during the course of treatment. The effect of TASTYLIA 5 on the ability to drive vehicles is minimal; however, if dizziness or visual disturbances occur, one should refrain from driving and operating machinery.

Where to buy TASTYLIA 5 in Ukraine

You can purchase TASTYLIA 5 in Ukraine at retail pharmacy chains that sell certified products from pharmaceutical companies, as well as through legal online medicine booking services. The drug is dispensed by prescription, so before buying it is necessary to obtain an appropriate prescription from a urologist, andrologist, or family doctor. This approach guarantees that the product will be used for its direct indication and taking into account the individual characteristics of the patient's body. TASTYLIA 5 should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children. The shelf life of the drug is usually 24 months from the date of manufacture, after which the use of the tablets is prohibited.

When purchasing, it is important to pay attention to the integrity of the packaging, the presence of protective holographic labeling, and the compliance of the batch of the drug with the data specified in the accompanying documentation. Original Healing Pharma products always have clear labeling, instructions in Ukrainian, and a registration certificate from the Ministry of Health of Ukraine. Online ordering allows you to conveniently compare prices in different pharmacies and choose the most favorable offer with delivery to the nearest branch or by courier. However, one should beware of dubious online stores that offer the drug without a prescription at an abnormally low price, as there is a risk of acquiring counterfeit products. Using a low-quality drug can be not only ineffective but also dangerous to health, so TASTYLIA 5 should be bought exclusively from trusted licensed suppliers.